Desirox医保能给予报销吗?
It was developed by Novartis and was the first oral iron chelator approved by the FDA for routine use in 2005. The FDA granted Desirox orphan drug status for the treatment of iron overload in non-transfusion-dependent thalassemia. It is currently on the market in more than 80 countries.
In 2010, Desirox was approved for marketing in China. So, can Desirox be reimbursed by medical insurance?
According to Medical Companion Travel, Desirox has not yet been officially included in medical insurance and cannot be reimbursed by medical insurance. It is a self-paid drug for patients!
The price of Desirox is relatively high after it is launched in China, with a box costing about $2,000. For an ordinary person weighing 60kg, the cost of taking Desirox for a month is more than about $24,000. It can be seen that it is difficult for ordinary families to accept this price and cannot afford it!
Fortunately, there are also foreign versions for everyone to choose from. Novartis of Switzerland imported Desirox to India. The specification is 400mg*30 tablets/box, and the price is about $700.
The specification of Desirox produced by Indian pharmaceutical factory is 500*30 tablets/box, and the price is about 500$. Due to the fluctuation of exchange rate, the price will be different. Please consult the medical companion for the specific price!
It can be used for patients with iron accumulation due to long-term blood transfusion (such as thalassemia or other rare anemias). It is suitable for children over two years old and adults. Corresponding to body weight, it is initially recommended to take Desirox at a daily dose of 20 mg/kg, depending on the improvement of serum ferritin indicators. Usage and dosage are based on the patient's personal condition, constitution, family genetic history, and drug ingredients. The drug is accurately selected to truly prescribe the right medicine for the disease. At the same time, the medicine is accurately administered in the appropriate method, appropriate dose, and appropriate time. Pay attention to drug contraindications, adverse reactions, interactions, etc.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)